Search Results - Fréderic Glauser

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Delayed manifestation of COVID-19 presenting as lower extremity multilevel arterial thrombosis: a case report

    Delayed manifestation of COVID-19 presenting as lower extremity multilevel arterial thrombosis: a case report by Cecilia Schweblin, Anne-Lise Hachulla, Marco Roffi, Fréderic Glauser

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines

    Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines by Pierre Fontana, Alessandro Casini, Helia Robert‐Ebadi, Fréderic Glauser, Marc Righini, Marc Blondon

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Management of high-risk pulmonary embolism in pregnancy

    Management of high-risk pulmonary embolism in pregnancy by Marc Blondon, Begoña Martínez de Tejada, Fréderic Glauser, Marc Righini, Helia Robert‐Ebadi

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Enhancing identification and treatment of patients with concomitant chronic venous insufficiency and diabetes mellitus. A modified Delphi study from the CODAC (ChrOnic venous disease and Diabetes Advisory Council) group

    Enhancing identification and treatment of patients with concomitant chronic venous insufficiency and diabetes mellitus. A modified Delphi study from the CODAC (ChrOnic venous disea... by Ahmet Bozkurt, Marie Josee van Rijn, Eliete Bouskela, Giacomo Gastaldi, Frederic Glauser, Hermann Haller, Juan Rosas-Saucedo, Daniel Zingg, Alessandra Calabrese, Eberhard Rabe, Armando Mansilha

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

    Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial by Stefano Barco, Davide Voci, Ulrike Held, Tim Sebastian, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, Andrè Frenk, B. Gerber, Andrea Götschi, Stavros Konstantinides, François Mach, Helia Robert‐Ebadi, Thomas Rosemann, Noemi R Simon, Hervé Spechbach, David Spirk, Stefan Stortecky, Lukas Vaisnora, Marc Righini, Nils Kucher, Stefano Barco, Davide Voci, Ulrike Held, Tim Sebastian, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, Andrè Frenk, B. Gerber, Andrea Götschi, Stavros Konstantinides, François Mach, Helia Robert‐Ebadi, Thomas Rosemann, Noemi R Simon, Hervé Spechbach, David Spirk, Stefan Stortecky, Lukas Vaisnora, Marc Righini, Nils Kucher, Stéphanie Roth Zetzsche, Rebecca Spescha, Claudia Leeger, Yulia Butscheid, Eliane Probst, Evy Micieli, Gábor Forgó, Fabian Johner, Alexandru Grigorean, Georgios Vatsakis, Dagmar Keller Lang, Silvana Rampini Speck, Barbara Hasse, Marco Rueegg, Isabelle C. Arnold, Christian H. Nickel, Jeannette Busch, Marc Blondon, Fréderic Glauser, Micol Giulia Cittone, Chiara Kessler, Diona Gjermeni, Christoph B. Olivier, Nadine Gauchel, Paul Biever, Lukas Hobohm, Dorothea Becker, Marc Schindewolf, Arnaud Kuenzi, Silvia Ulrich

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: